PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market
Sandusky, OH --
May 27, 2021 -- InvestorsHub NewsWire
-- PAO Group, Inc.
(USOTC:
PAOG) today highlighted Alkame Holdings, Inc’s (USOTC:
ALKM) recent news reporting the near completion status of its
new production facility:
ALKM –
Alkame Confirms $15 Million Annual Revenue Bottling Production
Potential
PAOG recenlty
released a preview of the company’s plan to launch a CBD
Nutraceuticals line of products. PAOG’s CBD Nutraceuticals
are expected to generate revenue this year, in 2021, while the
company continues with its long-term CBD pharmaceutical
developments.
PAOG plans to
develop and distribute its CBD nutraceuticals ALKM as a copacker
and North American Cannabis Holdings, Inc. (OTC
Pink: USMJ) as a
distributor.
The 2020 CBD
Nutraceuticals Market had an estimated
value of $5.2 Billion and it is expected to reach $16.4 Billion by
2027.
The first CBD
Nutraceutical under development will sell under the name CBD
RELAX-RX targeting the anxiety and depression treatment market
anticipated to reach a value
of $18 billion by
2025.
The second CBD
Nutraceutical under development will be derived from PAOG’s ongoing
COPD research targeting the COPD treatment market separately from
the pharmaceutical market also targeting COPD
treatment.
The third CBD
Nutraceutical is being developed in partnership with the EVERx CBD
Sports Water Brand owned by Puration, Inc. (USOTC:
PURA) and will target the sports nutrition
market.
Long-term, PAOG
is working on the development of a CBD pharmaceutical product under
the name RespRx, for the treatment of
Chronic Obstructive Pulmonary Disorder (COPD)
derived from a patented cannabis extraction method - U.S. Patent
No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING
HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS
PLANT."
Learn more about
PAOG at www.paogroupinc.com.
Forward-Looking
Statements: Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the company are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ
materially from those anticipated in such statements. Technical
complications, which may arise, could prevent the prompt
implementation of any strategically significant plan(s) outlined
above. The Company undertakes no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this release.
CONTACT
INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
PAO (PK) (USOTC:PAOG)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
PAO (PK) (USOTC:PAOG)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
PAO Group Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More PAO Group Inc (PK) News Articles